Pfizer/BioNTec vaccines proved 95% effective, finds the largest study
Health
Thu, May 06, 2021
PARIS: The largest real-world study yet of the Pfizer/BioNTec vaccine on Thursday confirmed that the jab provided more than 95 percent protection against Covid-19, but found that the level dropped significantly when people received just one of the two prescribed doses.
The authors of the research from Israel´s national vaccination campaign said it showed real-world proof that the pandemic could be ended by rapid, global vaccination programmes.
An analysis of public health data from Israel -- one of the countries with the highest proportion of fully vaccinated adults -- showed the vaccine was extremely effective in protecting even elderly individuals at a time when the more infectious English variant was dominant, according to the results published in the Lancet medical journal.